Lung Cancer TALK: A Review of Data from the IASLC 2020 World Conference on Lung Cancer - Episode 6

WCLC Updates in Small Cell Lung Cancer

, , ,

Panelists provide first impressions on recent clinical trials in the treatment of small cell lung cancer and comment on the safety and efficacy of study treatments.

EP. 1: WCLC Updates in KRAS and Rare EGFR-Mutated NSCLC
EP. 2: WCLC Updates on the Emergence of ADCs in NSCLC
EP. 3: WCLC Updates in Immunotherapy for NSCLC
EP. 4: WCLC Updates in Neoadjuvant Therapy for NSCLC
EP. 5: WCLC Updates in Locally Advanced NSCLC
Now Viewing
EP. 6: WCLC Updates in Small Cell Lung Cancer

Data from the following clinical trials are discussed:

  • P15.01 - AMG 757, a Half-life Extended Bispecific T-Cell Engager (HLE BiTE® Immune Therapy) Targeting DLL3, for the Treatment of Small Cell Lung Cancer
  • OA11.04 - Lurbinectedin With Irinotecan in Relapsed Small Cell Lung Cancer. Results From the Expansion Stage of a Phase I/II Trial